Upgrade to SI Premium - Free Trial

Mizuho on Arcus Biosciences (RCUS): stock's dip today 'doesn't make sense'

April 20, 2026 12:05 PM
Mizuho analyst Salim Syed reiterated an Outperform rating and $47.00 price target on Arcus Biosciences (NYSE: RCUS)The analyst commented, "RCUS ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments